GILEAD SCIENCES, INC. Repayments of Other Debt
GILEAD SCIENCES, INC. (GILD) reported Repayments of Other Debt of $77.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2014-02-25.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfOtherDebt · last filed 2014-02-25
- GILEAD SCIENCES, INC. repayments of other debt for the quarter ending 2013-12-31 was $19.00K, a 0.00% change year-over-year.
- GILEAD SCIENCES, INC. repayments of other debt for the quarter ending 2013-09-30 was $20.00K, a 25.00% increase year-over-year.
- GILEAD SCIENCES, INC. repayments of other debt for the quarter ending 2013-06-30 was $18.00K, a 98.83% decline year-over-year.
- GILEAD SCIENCES, INC. repayments of other debt for the quarter ending 2013-03-31 was $20.00K, a 96.73% decline year-over-year.
- GILEAD SCIENCES, INC. repayments of other debt for fiscal 2013 was $77.00K, a 96.48% decline from fiscal 2012.
- GILEAD SCIENCES, INC. repayments of other debt for fiscal 2012 was $2.19M, a 39.95% increase from fiscal 2011.
- GILEAD SCIENCES, INC. repayments of other debt for fiscal 2011 was $1.56M, a 73.00% decline from fiscal 2010.
- GILEAD SCIENCES, INC. repayments of other debt for fiscal 2010 was $5.79M, a 2.44% increase from fiscal 2009.
| Period end | Repayments of Other Debt 3 month | Repayments of Other Debt 6 month | Repayments of Other Debt 9 month | Repayments of Other Debt 12 month |
|---|---|---|---|---|
| 2013-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $39.00K derived: sum of 2 quarters · filed 2014-02-25 | $57.00K derived: sum of 3 quarters · filed 2014-02-25 | $77.00K 10-K · filed 2014-02-25 |
| 2013-09-30 | $20.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $38.00K derived: sum of 2 quarters · filed 2013-10-31 | $58.00K 10-Q · filed 2013-10-31 | $77.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2013-06-30 | $18.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $38.00K 10-Q · filed 2013-08-01 | $57.00K derived: sum of 3 quarters · filed 2014-02-25 | $73.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2013-03-31 | $20.00K 10-Q · filed 2013-05-08 | $39.00K derived: sum of 2 quarters · filed 2014-02-25 | $55.00K derived: sum of 3 quarters · filed 2014-02-25 | $1.59M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-12-31 | $19.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $35.00K derived: sum of 2 quarters · filed 2014-02-25 | $1.57M derived: sum of 3 quarters · filed 2014-02-25 | $2.19M 10-K · filed 2014-02-25 |
| 2012-09-30 | $16.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $1.55M derived: sum of 2 quarters · filed 2013-10-31 | $2.17M 10-Q · filed 2013-10-31 | $2.11M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | $1.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | $2.15M 10-Q · filed 2013-08-01 | $2.09M derived: sum of 3 quarters · filed 2014-02-25 | $2.15M derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-03-31 | $612.00K 10-Q · filed 2013-05-08 | $555.00K derived: sum of 2 quarters · filed 2014-02-25 | $607.00K derived: sum of 3 quarters · filed 2014-02-25 | $641.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2011-12-31 | -$57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$5.00K derived: sum of 2 quarters · filed 2014-02-25 | $29.00K derived: sum of 3 quarters · filed 2014-02-25 | $1.56M 10-K · filed 2014-02-25 |
| 2011-09-30 | $52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $86.00K derived: sum of 2 quarters · filed 2012-11-06 | $1.62M 10-Q · filed 2012-11-06 | $1.82M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $1.57M 10-Q · filed 2012-08-01 | $1.76M derived: sum of 3 quarters · filed 2013-02-27 | $1.80M derived: sum of 4 quarters · filed 2013-02-27 |
| 2011-03-31 | $1.53M 10-Q · filed 2012-05-04 | $1.73M derived: sum of 2 quarters · filed 2013-02-27 | $1.76M derived: sum of 3 quarters · filed 2013-02-27 | $7.30M derived: sum of 4 quarters · filed 2013-02-27 |
| 2010-12-31 | $197.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | $230.00K derived: sum of 2 quarters · filed 2013-02-27 | $5.77M derived: sum of 3 quarters · filed 2013-02-27 | $5.79M 10-K · filed 2013-02-27 |
| 2010-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $5.57M derived: sum of 2 quarters · filed 2011-11-04 | $5.59M 10-Q · filed 2011-11-04 | $5.63M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-06-30 | $5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | $5.56M 10-Q · filed 2011-08-05 | $5.60M derived: sum of 3 quarters · filed 2012-02-23 | $11.12M derived: sum of 4 quarters · filed 2012-02-23 |
| 2010-03-31 | $19.00K 10-Q · filed 2011-05-09 | $60.00K derived: sum of 2 quarters · filed 2012-02-23 | $5.59M derived: sum of 3 quarters · filed 2012-02-23 | $5.63M derived: sum of 4 quarters · filed 2012-02-23 |
| 2009-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $5.57M derived: sum of 2 quarters · filed 2012-02-23 | $5.61M derived: sum of 3 quarters · filed 2012-02-23 | $5.65M 10-K · filed 2012-02-23 |
| 2009-09-30 | $5.53M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $5.57M derived: sum of 2 quarters · filed 2010-11-08 | $5.61M 10-Q · filed 2010-11-08 | $6.18M derived: sum of 4 quarters · filed 2011-02-28 |
| 2009-06-30 | $44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $80.00K 10-Q · filed 2010-08-09 | $657.00K derived: sum of 3 quarters · filed 2011-02-28 | $4.21M derived: sum of 4 quarters · filed 2011-02-28 |
| 2009-03-31 | $36.00K 10-Q · filed 2010-05-10 | $613.00K derived: sum of 2 quarters · filed 2011-02-28 | $4.17M derived: sum of 3 quarters · filed 2011-02-28 | |
| 2008-12-31 | $577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | $4.13M derived: sum of 2 quarters · filed 2011-02-28 | $4.33M 10-K · filed 2011-02-28 | |
| 2008-09-30 | $3.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $3.75M 10-Q · filed 2009-11-05 | ||
| 2008-06-30 | $193.00K 10-Q · filed 2009-08-05 | |||
| 2007-12-31 | $99.46M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |